193. BMC Cancer. 2018 Mar 12;18(1):280. doi: 10.1186/s12885-018-4182-3.Reproductive risk factors in breast cancer and genetic hormonal pathways: agene-environment interaction in the MCC-Spain project.Dierssen-Sotos T(1)(2), Palazuelos-Calderón C(1), Jiménez-Moleón JJ(2)(3),Aragonés N(2)(4)(5), Altzibar JM(2)(6), Castaño-Vinyals G(2)(7)(8)(9),Martín-Sanchez V(2)(10), Gómez-Acebo I(1)(2), Guevara M(2)(11), Tardón A(2)(12), Pérez-Gómez B(2)(4)(5), Amiano P(2)(13), Moreno V(2)(14)(15), Molina AJ(10),Alonso-Molero J(1), Moreno-Iribas C(11)(16), Kogevinas M(2)(7)(8)(9), PollánM(2)(4)(5), Llorca J(17)(18)(19).Author information: (1)Universidad de Cantabria - IDIVAL, Santander, Spain.(2)CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.(3)Universidad de Granada - ibs.Granada, Granada, Spain.(4)Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029, Madrid,Spain.(5)Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puertade Hierro (IDIPHIM), Manuel de Falla 1, 28222, Madrid, Spain.(6)Breast Cancer Early Detection Programme, Basque Health Service-Osakidetza, SanSebastian, Spain.(7)ISGlobal, Centre for Research in Environmental Epidemiology (CREAL),Barcelona, Spain.(8)IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.(9)Universitat Pompeu Fabra (UPF), Barcelona, Spain.(10)Universidad de León, León, Spain.(11)Public Health Institute of Navarra, IdiSNA, Pamplona, Spain.(12)IUOPA, Universidad de Oviedo, Asturias, Spain.(13)Public Health Division of Gipuzkoa, BioDonostia Research Health Institute,San Sebastian, Spain.(14)IDIBELL-Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.(15)Department of Clinical Sciences, Faculty of Medicine, University ofBarcelona, Barcelona, Spain.(16)Health Services Research on Chronic Patients Network, REDISSEC, Valencia,Spain.(17)Universidad de Cantabria - IDIVAL, Santander, Spain. javier.llorca@unican.es.(18)CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.javier.llorca@unican.es.(19)Facultad de Medicina, Universidad de Cantabria, Avda. Herrera Oria s/n,39011, Santander, Spain. javier.llorca@unican.es.BACKGROUND: Reproductive factors are well known risk factors for breast cancer;however, little is known about how genetic variants in hormonal pathways interactwith that relationship.METHODS: One thousand one hundred thirty nine cases of breast cancer in women and1322 frequency-matched controls were compared. Genetic variants in hormonalpathways (identified in the Kyoto Encyclopedia of Genes and Genomes) werescreened according to their relationship with breast cancer using theCochran-Armitage statistic. Information on reproductive factors was obtainedusing a face-to-face questionnaire. The interaction among the selected geneticvariants and reproductive factors was tested with logistic regression.RESULTS: Concerning C allele in rs2229712, compared to nulliparity innon-carriers the ORs for 1-2 and > 2 deliveries were 0.48 (0.28-0.81) and 0.34(0.19-0.59), and in C carriers they were 0.92 (0.42-1.98) and 0.71 (0.31-1.61).Similar results were found in women carrying the C allele in rs1269851. Carriers of Allele T in rs35652107 and allele C in rs6018027 had the delivery numbereffect more pronounced.CONCLUSIONS: The number of deliveries had a dose-response protective effect onbreast cancer; women carrying C allele in rs2229712 did not benefit from thisprotective effect.DOI: 10.1186/s12885-018-4182-3 PMCID: PMC5848450PMID: 29530003 